Liver X receptor-dependent inhibition of microglial nitric oxide synthase 2
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The nuclear receptor liver X receptor (LXR) exerts transcriptional control over lipid metabolism and inflammatory response in cells of the myeloid lineage, suggesting that LXR may be a potential target in a number of chronic neuroinflammatory and neurodegenerative diseases where persistent microglial activation has been implicated in the pathogenesis. METHODS: The effect of LXR activation on microglia and central nervous system (CNS) inflammation was studied using a synthetic LXR agonist in cultured microglia, a microglial cell line and experimental allergic encephalomyelitis (EAE), an animal model of CNS inflammation. RESULTS: LXR activation inhibited nitric oxide synthase 2, inducible (Nos2) expression and nitric oxide production in lipopolysaccharide (LPS)-stimulated microglia. Inhibition of microglial activation in response to interferon-γ was less reliable. In LPS-stimulated cells, LXR activation did not inhibit nuclear translocation of NF-kappaB1 p50. Instead, LXR-dependent Nos2 repression was associated with inhibition of histone 4 acetylation and inhibition of NF-kappaB1 p50 binding at the Nos2 promoter. Histone acetylation and NF-kappaB1 p50 binding were mechanistically linked, and histone deacetylase (HDAC) activity appeared to be important for LXR-dependent transcriptional repression of Nos2. Analysis of CNS gene expression in animals undergoing EAE showed that the expressions of Lxr and LXR-dependent genes were downregulated during CNS inflammation. Nevertheless, administration of LXR agonist GW3965 during the effector phase of EAE delayed the onset of clinical disease and reversed the diminished expression of LXR-dependent reverse cholesterol transport genes. However, the CNS expressions of Nos2 and other inflammatory genes were not significantly inhibited by LXR activation in EAE, and clinical disease severity was comparable to vehicle controls at later time points in LXR agonist treated animals. CONCLUSIONS: LXR can be targeted to modulate microglial activation. LXR-dependent repression of inflammatory genes may be stimulus-dependent and impaired by HDAC inhibition. Endogenous LXR activity does not appear to modulate CNS inflammation, but LXR activity can be partially restored in the CNS by administration of exogenous LXR agonist with an impact on clinical disease severity at early, but not late, time points in EAE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These observations agree with known anti-inflammatory and Aβ-clearing effects of LXRα/β agonists in AD models [40–42] as well as the role of Cebpα in regulating PU.1 which maintains microglial quiescence [43].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Agonists of LXRα/β, predicted to specifically promote anti-inflammatory DAM gene expression in our network analysis, have anti-inflammatory and protective effects in AD models [40, 41].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Relative quantitation of mRNA was performed using the comparative threshold (delta delta CT) method [17] using Actb as endogenous control.”
MethodMicroglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 2×
“Discussion Persistent microglial activation has been implicated in the pathogenesis of a number of neuroinflammatory and neurodegenerative disorders [2].”
BackgroundMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591 · cited 1×
“The liver X receptor (LXR) is an oxysterol-activated nuclear receptor [6].”
BackgroundA SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254 · cited 1×
“Whereas genes involved in reverse cholesterol transport are coordinately regulated by LXR transcriptional activation involving exchange of NCoR for NCoA, the antiinflammatory effects of LXR are under SUMOylation-dependent transcriptional repression [35].”
BackgroundReciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158 · cited 3×
“In cells of the myeloid lineage, LXR has also been shown to control inflammatory responses by transcriptional repression of a number of genes including Nos2, Cox2 and Il6 [10].”
BackgroundInfluentialExacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071 · cited 1×
“Stimulus-specific differences in LXR-dependent inhibition are likely to be important in neuroinflammatory diseases such as multiple sclerosis, where both Toll-like receptor and interferon-γ signaling have been reported [26-29].”
BackgroundLowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., & Murphy, W. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9730 · Cited by 1,064 · cited 1×
“We detected peak of LPSinduced NF-kappaB1 p50 binding at −159 to −15 bases upstream of the Nos2 transcription start site, which corresponds to the previously reported proximal enhancer cluster on the Nos2 promoter [31].”
BackgroundControl of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα
Venkateswaran, A., Laffitte, B. A., Joseph, S. B., Mak, P. A., Wilpitz, D. C., Edwards, P. A., & Tontonoz, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200367697 · Cited by 1,005 · cited 1×
“LXR is known to control the expression of genes involved in reverse cholesterol transport such as Abca1, Abcg1, Apoa1, Apoe and Cyp7a1 [8,9].”
BackgroundInflammation and Lipid Signaling in the Etiology of Insulin Resistance
Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 935 · cited 1×
“Thus, LXR is one among a number of biological signal pathways that link lipid metabolism and inflammation [11].”
BackgroundExperimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 1×
“Inhibiting microglial activation or function has the potential to ameliorate neuroinflammatory and neurodegenerative disorders [4,5].”
BackgroundBowers, E. M., Yan, G., Mukherjee, C., Orry, A., Wang, L., Holbert, M. A., Crump, N. T., Hazzalin, C. A., Liszczak, G., Yuan, H., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.006 · Cited by 666 · cited 1×
“To investigate the relationship between histone acetylation and NF-kappaB1 p50 binding at the Nos2 promoter, cells were pretreated with C646, an inhibitor of histone acetyltransferase [24].”
MethodMolecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647 · cited 1×
“These results are in agreement with previous studies that identified Nos2 and Il1b, but not Tnf, as LXRrepressed genes [25].”
ResultMicroglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease
Fuhrmann, M., Bittner, T., Jung, C. K. E., Burgold, S., Page, R. M., Mitteregger, G., Haass, C., LaFerla, F. M., Kretzschmar, H., & Herms, J. (2010) · Nature Neuroscience · doi:10.1038/nn.2511 · Cited by 562 · cited 1×
“Inhibiting microglial activation or function has the potential to ameliorate neuroinflammatory and neurodegenerative disorders [4,5].”
BackgroundGhisletti, S., Huang, W., Ogawa, S., Pascual, G., Lin, M.-E., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.022 · Cited by 561 · cited 2×
“A previous study showed that ligand-dependent transcriptional repression by LXR involves post-translational modification by SUMOylation and subsequent stabilization of the LXR-NCoR complex on the promoters of target genes [7].”
BackgroundExperimental Autoimmune Encephalomyelitis in the Mouse
Miller, S. D., & Karpus, W. J. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im1501s77 · Cited by 401
Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis
Prinz, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26078 · Cited by 380 · cited 2×
“Therefore, CNS inflammatory conditions such as EAE and MS where both Toll-like receptor and interferon-γ signaling are detected may be less responsive to inhibitory action of LXR [26,27].”
BackgroundBlock, M. L., Wu, X., Pei, Z., Li, G., Wang, T., Qin, L., Wilson, B., Yang, J., Hong, J. S., & Veronesi, B. (2004) · The FASEB Journal · doi:10.1096/fj.04-1945fje · Cited by 376
Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2
Sloane, J. A., Batt, C., Ma, Y., Harris, Z. M., Trapp, B., & Vartanian, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006496107 · Cited by 360 · cited 2×
“Therefore, CNS inflammatory conditions such as EAE and MS where both Toll-like receptor and interferon-γ signaling are detected may be less responsive to inhibitory action of LXR [26,27].”
BackgroundUnderhill, C., Qutob, M. S., Yee, S.-P., & Torchia, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007864200 · Cited by 306 · cited 2×
“Histone deacetylase (HDAC) and BRG1 are components of the NCoR complex, suggesting that the mechanism of LXR-dependent transcriptional repression involves epigenetic modification [22,30].”
BackgroundLiver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation
Cui, G., Qin, X., Wu, L., Zhang, Y., Sheng, X., Yu, Q., Sheng, H., Xi, B., Zhang, J. Z., & Zang, Y. Q. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42974 · Cited by 271 · cited 4×
“Two previous studies examined the effect of LXR agonist administered during the induction phase [14,38], whereas LXR agonist was administered during the effector phase in the current study.”
BackgroundMethodInfluentialT0901317 is a potent PXR ligand: Implications for the biology ascribed to LXR
Mitro, N., Vargas, L., Romeo, R., Koder, A., & Saez, E. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.03.047 · Cited by 250 · cited 1×
“T0901317 has turned out to be a rather non-specific LXR agonist, with additional activity toward pregnane X receptor and farnesoid X receptor, not seen in GW3965 [39,40].”
BackgroundWoodroofe, M. N., & Cuzner, M. L. (1993) · Cytokine · doi:10.1016/s1043-4666(05)80008-0 · Cited by 243
Microglia: Multiple roles in surveillance, circuit shaping, and response to injury
Benarroch, E. E. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a4a577 · Cited by 223 · cited 1×
“Background Microglia are resident innate immune cells of the CNS and contribute to CNS inflammation and repair through multiple functions including scavenging, phagocytosis, antigen presentation and production of reactive oxygen/ nitrogen species, cytokines and neurotropic factors [1].”
BackgroundPeroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress
Juurlink, B. H. J., Thorburne, S. K., & Hertz, L. (1998) · Glia · doi:10.1002/(sici)1098-1136(199804)22:4<371::aid-glia6>3.0.co;2-6 · Cited by 196
T0901317 is a dual LXR/FXR agonist
Houck, K. A., Borchert, K. M., Hepler, C. D., Thomas, J. S., Bramlett, K. S., Michael, L. F., & Burris, T. P. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.07.007 · Cited by 186 · cited 1×
“T0901317 has turned out to be a rather non-specific LXR agonist, with additional activity toward pregnane X receptor and farnesoid X receptor, not seen in GW3965 [39,40].”
BackgroundExperimental Autoimmune Encephalomyelitis in the Mouse
Miller, S. D., Karpus, W. J., & Davidson, T. S. (2010) · Current Protocols in Immunology · doi:10.1002/0471142735.im1501s88 · Cited by 173
Kim, M. S., Sweeney, T. R., Shigenaga, J. K., Chui, L. G., Moser, A., Grunfeld, C., & Feingold, K. R. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.007 · Cited by 168 · cited 1×
“In hepatocytes, renal cells and adipocytes, induction of acute phase response by LPS, TNF and/or IL-1β is associated with reduction in nuclear receptor levels including LXR [32-34].”
BackgroundDetection of Intracellular Cytokines by Flow Cytometry
Yin, Y., Mitson‐Salazar, A., & Prussin, C. (2015) · Current Protocols in Immunology · doi:10.1002/0471142735.im0624s110 · Cited by 162
Lee, J. H., Park, S. M., Kim, O. S., Lee, C. S., Woo, J. H., Park, S. J., Joe, E.-H., & Jou, I. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.07.021 · Cited by 161 · cited 1×
“However, LXRdependent repression of inflammatory genes has been reported in multiple cell types including astrocytes [37] and therefore would have been expected to have broader antiinflammatory effects.”
BackgroundDetection of Intracellular Cytokines by Flow Cytometry
Foster, B., Prussin, C., Liu, F., Whitmire, J. K., & Whitton, J. L. (2007) · Current Protocols in Immunology · doi:10.1002/0471142735.im0624s78 · Cited by 124 · cited 1×
“Cells were then plated in 24-well plates and stimulated with PMA/ ionomycin/brefeldin A for 6 h as previously described [21].”
MethodZhang-Gandhi, C. X., & Drew, P. D. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.007 · Cited by 117 · cited 1×
“Previous studies have shown that activation of LXR by oxysterols inhibits proinflammatory responses in cultures of microglia and astrocytes, suggesting that the LXR pathway might serve a compensatory antiinflammatory function in response to oxidative stress [12,13].”
BackgroundMechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease
Lassmann, H. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0607-8 · Cited by 112 · cited 2×
“Reactive oxygen species, reactive nitrogen species and inflammatory cytokines have been identified as potentially deleterious products of chronic microglial activation in these disorders, leading to oxidative stress and mitochondrial dysfunction [3].”
BackgroundLiver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis
Hindinger, C., Hinton, D. R., Kirwin, S. J., Atkinson, R. D., Burnett, M. E., Bergmann, C. C., & Stohlman, S. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21038 · Cited by 101 · cited 2×
“A previous study tested a different LXR agonist (T091317) during the effector phase of EAE [38].”
MethodNF-?B modulates lipopolysaccharide-induced microglial nerve growth factor expression
Heese, K., Fiebich, B. L., Bauer, J., & Otten, U. (1998) · Glia · doi:10.1002/(sici)1098-1136(199804)22:4<401::aid-glia9>3.0.co;2-5 · Cited by 97 · cited 1×
“To examine the effect of LXR activation on histone modification at the Nos2 promoter and its impact on LPS-induced NF-kappaB signaling [23], ChIP was performed on microglial cell line BV2 using antibodies specific to acetylated histone 4 and NF-kappaB1 p50.”
MethodA Novel Principle for Partial Agonism of Liver X Receptor Ligands
Albers, M., Blume, B., Schlueter, T., Wright, M. B., Kober, I., Kremoser, C., Deuschle, U., & Koegl, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510101200 · Cited by 95 · cited 1×
“There is evidence that the activation and repression functions of LXR can be uncoupled [36].”
BackgroundLiver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity
Xu, J., Wagoner, G., Douglas, J. C., & Drew, P. D. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1008600 · Cited by 81 · cited 1×
“In addition, previous studies have shown that LXR agonists reduced the severity of experimental allergic encephalomyelitis (EAE), an animal model of neuroinflammation, during its induction phase by an immunomodulatory effect on T helper lymphocyte differentiation [14,15].”
BackgroundWang, Y., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500134-jlr200 · Cited by 81 · cited 1×
“In hepatocytes, renal cells and adipocytes, induction of acute phase response by LPS, TNF and/or IL-1β is associated with reduction in nuclear receptor levels including LXR [32-34].”
BackgroundLu, B., Moser, A. H., Shigenaga, J. K., Feingold, K. R., & Grunfeld, C. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500540-jlr200 · Cited by 47 · cited 1×
“In hepatocytes, renal cells and adipocytes, induction of acute phase response by LPS, TNF and/or IL-1β is associated with reduction in nuclear receptor levels including LXR [32-34].”
BackgroundFeldmann, R., Fischer, C., Kodelja, V., Behrens, S., Haas, S. A., Vingron, M., Timmermann, B., Geikowski, A., & Sauer, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt034 · Cited by 41 · cited 1×
“LXR is known to control the expression of genes involved in reverse cholesterol transport such as Abca1, Abcg1, Apoa1, Apoe and Cyp7a1 [8,9].”
BackgroundKim, O. S., Lee, C. S., Joe, E.-H., & Jou, I. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.107 · Cited by 34 · cited 1×
“Previous studies have shown that activation of LXR by oxysterols inhibits proinflammatory responses in cultures of microglia and astrocytes, suggesting that the LXR pathway might serve a compensatory antiinflammatory function in response to oxidative stress [12,13].”
BackgroundActivation of ATP-Binding Cassette Transporter A1 Transcription by Chromatin Remodeling Complex
Huuskonen, J., Vishnu, M., Fielding, P. E., & Fielding, C. J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163186.58462.c5 · Cited by 15 · cited 1×
“Histone deacetylase (HDAC) and BRG1 are components of the NCoR complex, suggesting that the mechanism of LXR-dependent transcriptional repression involves epigenetic modification [22,30].”
Background
Cited by
Rangaraju, S., Dammer, E. B., Raza, S. A., Rathakrishnan, P., Xiao, H., Gao, T., Duong, D. M., Pennington, M. W., Lah, J. J., Seyfried, N. T., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0254-8 · Cited by 430
Shao, F., Wang, X., Wu, H., Wu, Q., & Zhang, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.825086 · Cited by 250
Transcriptional control of microglia phenotypes in health and disease
Holtman, I. R., Skola, D., & Glass, C. K. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90604 · Cited by 218
Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer
Bilotta, M. T., Petillo, S., Santoni, A., & Cippitelli, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584303 · Cited by 171
Qiu, L., Ji, M., Zhang, H., Yang, J., Sun, X.-R., Tang, H., Wang, J., Liu, W., & Yang, J.-J. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.002 · Cited by 135
“Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is an important source of the production of ROS in phagocytes including microglia (Sorce and Krause, 2009).”
Background
Metadata
- Authors
- Secor McVoy, J. R., Oughli, H. A., & Oh, U.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Oh, Unsong
- Venue
- Journal of Neuroinflammation
- Published
- 2015-02-10
- Volume
- 12
- Issue
- 1
- Pages
- 27-27
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC4332930
- OpenAlex
- W2169725287
- Cited by
- 34
- References
- 43
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 2
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- VCU Scholars Compass (Virginia Commonwealth University) (submittedVersion, cc-by)
- Funders
- Georgia Clinical and Translational Science Alliance (KL2TR000057)
- National Institutes of Health (KL2TR000057)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- liver X receptor, microglial activation, nitric oxide synthase 2, experimental autoimmune encephalomyelitis, neuroinflammation, histone deacetylase, histone acetylation, NF-κB p50, transcriptional repression, GW3965, reverse cholesterol transport, lipopolysaccharide, interferon-gamma
- MeSH terms
- Liver X Receptors, Animals, Animals, Newborn, Benzoates, Benzylamines, Cells, Cultured, Deoxyribonucleases, Encephalomyelitis, Autoimmune, Experimental, Histones, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Inbred ICR, Peptide Fragments, Protein Binding, Cytokines, Microglia, Gene Expression Profiling, RNA, Small Interfering, Chromatin Immunoprecipitation, Mice, Nitric Oxide Synthase Type II, Orphan Nuclear Receptors, Myelin-Oligodendrocyte Glycoprotein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.